WHAT IS DIPHTHERIA? SYMPTOMS, CAUSES & TREATMENT.

• Facebook
• X
• Line

KEY TAKEAWAYS

• Diphtheria is a contagious bacterial infection that affects the throat and nose.
• Early diagnosis and treatment with antitoxin and antibiotics prevent serious complications.
• Vaccination provides strong, long-term protection and helps stop the spread of disease.

Diphtheria may sound like a disease from the past, but it still poses a real threat wherever vaccination rates drop. Caused by the bacterium Corynebacterium diphtheriae, this infection targets your throat and nose, sometimes spreading toxins that harm your heart, nerves, and other organs. Diphtheria is a serious bacterial infection that can become life-threatening without prompt diagnosis and treatment.

You can catch diphtheria through droplets from coughing or sneezing, and even mild cases can spread the bacteria to others. Symptoms often start with a sore throat, fever, and swollen neck glands, followed by a thick gray coating in the throat that makes breathing difficult. Quick medical care with antitoxin and antibiotics can stop the infection from worsening and prevent severe complications.

Vaccination remains your best defense. Routine immunization protects not only you but also your community by preventing outbreaks that still occur in areas with low vaccine coverage.

CONTENTS

1. WHAT IS DIPHTHERIA?

• DEFINITION AND OVERVIEW
• TYPES OF DIPHTHERIA
• DIPHTHERIA TOXIN AND PATHOPHYSIOLOGY

2. SYMPTOMS AND COMPLICATIONS

• EARLY SIGNS AND SYMPTOMS
• HALLMARK FEATURES OF DIPHTHERIA
• SEVERE COMPLICATIONS
• LONG-TERM EFFECTS

3. CAUSES AND TRANSMISSION

• BACTERIAL CAUSES
• MODES OF TRANSMISSION
• RISK FACTORS FOR INFECTION

4. DIAGNOSIS AND TESTING

• CLINICAL DIAGNOSIS
• LABORATORY CONFIRMATION
• DIFFERENTIAL DIAGNOSIS

5. TREATMENT AND MANAGEMENT

• IMMEDIATE MEDICAL RESPONSE
• MEDICATIONS AND THERAPIES
• MANAGING SEVERE CASES

6. PREVENTION AND IMMUNIZATION

• DIPHTHERIA VACCINATION
• IMMUNIZATION SCHEDULES
• PUBLIC HEALTH STRATEGIES

Diphtheria is an infectious disease caused by Corynebacterium diphtheriae, a toxin-producing bacterium that primarily attacks the upper respiratory tract and sometimes the skin. It spreads through respiratory droplets or direct contact with infected wounds and can cause serious complications if untreated. Vaccination remains the most effective way to prevent infection and transmission.

You encounter diphtheria when Corynebacterium diphtheriae infects the mucous membranes of the nose, throat, or skin. The infection often begins in the upper respiratory tract, where the bacteria release toxins that damage local tissues.

A hallmark sign is a thick gray pseudomembrane that forms over the tonsils, throat, or nasal passages. This layer can obstruct breathing and swallowing. Other symptoms include fever, sore throat, swollen neck glands, and weakness.

Before vaccines became widespread, diphtheria caused large outbreaks and high mortality, especially in children. Today, it is rare in countries with strong immunization programs but still appears in areas with low vaccine coverage. Early diagnosis and treatment are essential to prevent severe complications such as heart or nerve damage.

Diphtheria appears in several clinical forms depending on the site of infection. The two main types are respiratory diphtheria and cutaneous diphtheria.

Respiratory diphtheria affects the throat, nose, or larynx. It causes the formation of a pseudomembrane and can lead to airway obstruction. When the infection involves the larynx, it may result in laryngeal diphtheria, producing hoarseness, difficulty breathing, and a barking cough.

Cutaneous diphtheria affects the skin. It produces ulcers or sores that may be covered by a gray membrane. Although usually less severe, it can still spread the bacteria to others.

Rarely, diphtheria can infect other mucosal sites or cause systemic illness when the toxin spreads through the bloodstream. Regardless of location, unvaccinated individuals face the highest risk of serious disease.

The danger of diphtheria lies in its exotoxin, a powerful protein produced by toxin-carrying strains of C. diphtheriae. This diphtheria toxin blocks protein synthesis inside host cells, leading to cell death and tissue necrosis.

Locally, the toxin destroys epithelial cells in the throat or skin, forming the pseudomembrane composed of dead tissue, bacteria, and fibrin. When the toxin enters the bloodstream, it can damage distant organs.

Systemic effects include myocarditis (inflammation of the heart muscle) and neuritis (nerve inflammation), which may cause heart failure or paralysis. Prompt administration of diphtheria antitoxin and antibiotics can neutralize circulating toxin and halt bacterial growth, reducing the risk of these life-threatening complications.

Diphtheria affects the upper respiratory tract and sometimes the skin, leading to symptoms that can progress from mild discomfort to life‑threatening complications. The illness can damage the heart, nerves, and respiratory system, and its severity depends on how quickly you receive treatment.

You may first notice a sore throat, mild fever, and swollen glands in your neck. These symptoms often appear two to five days after exposure to Corynebacterium diphtheriae. Fatigue, hoarseness, and difficulty swallowing can follow as the infection spreads in the pharynx or tonsils.

Breathing may become noisy or strained, sometimes resembling a barking cough. In some cases, nasal discharge or minor skin lesions appear, especially in cutaneous diphtheria. These skin infections can cause ulcers with a clear edge, redness, and mild pain.

Early recognition is critical because mild symptoms can quickly worsen. If you or your child develop throat pain with swelling and fever after possible exposure, seek medical care immediately to prevent complications.

A defining sign of respiratory diphtheria is the formation of a pseudomembrane—a thick, grayish layer made of dead tissue, bacteria, and immune cells. It forms across the throat, tonsils, or nasal passages and can make it hard to breathe or swallow.

This membrane may bleed if disturbed and can extend downward into the larynx or trachea, causing severe airway obstruction. The presence of this membrane distinguishes diphtheria from many other throat infections.

You might also notice hoarseness, pain when swallowing, or a swollen neck sometimes referred to as a “bull neck.” Without prompt treatment, the membrane and swelling can block airflow, requiring emergency intervention to restore breathing.

When the diphtheria toxin enters the bloodstream, it can damage internal organs. The most serious outcomes include myocarditis (inflammation of the heart muscle), polyneuropathy (nerve damage), and kidney injury.

Myocarditis can cause irregular heart rhythms or heart failure. Polyneuropathy may lead to weakness, difficulty moving, or paralysis of the soft palate and limbs. In some cases, pneumonia develops as a secondary infection.

Even with treatment, the mortality rate for respiratory diphtheria remains about 5–10%, and it is higher in young children and older adults. Rapid use of antitoxin and antibiotics reduces the risk of these outcomes.

Recovery from diphtheria can take weeks or months, depending on the severity. Nerve damage may cause temporary or lasting paralysis, especially in the throat or limbs, leading to problems with swallowing or movement.

Heart inflammation can leave residual weakness or rhythm disturbances. Some people experience prolonged fatigue or shortness of breath after severe infection.

In cutaneous diphtheria, scarring may occur at the site of infection, though long-term effects are uncommon. Ongoing medical follow-up ensures that any delayed complications, especially involving the heart or nerves, are identified and managed promptly.

Diphtheria develops when specific bacteria release toxins that damage tissues in your body. You can become infected through direct contact with these bacteria or with respiratory droplets and contaminated materials. Understanding how the bacteria spread and who faces the highest risk helps you prevent infection and protect others.

Diphtheria results mainly from Corynebacterium diphtheriae, a toxin-producing bacterium. The toxin, not the bacteria itself, causes most of the severe symptoms by destroying healthy cells and forming thick gray membranes in the throat and nose.

Some strains of Corynebacterium ulcerans can also produce a similar toxin and cause diphtheria-like illness. These infections sometimes occur after contact with infected animals or consumption of unpasteurized dairy products, making them zoonotic in nature.

Only toxin-producing strains lead to classic diphtheria. Non–toxin-producing Corynebacterium species can still cause mild skin or wound infections but are generally less dangerous. Proper identification in the laboratory is essential for accurate diagnosis and treatment.

You usually get diphtheria through respiratory secretions when an infected person coughs or sneezes. Tiny droplets carrying C. diphtheriae can enter your body when you breathe them in, especially in crowded or poorly ventilated areas.

Direct contact with open sores or ulcers from an infected person can also spread the bacteria. In rare cases, you may pick up the bacteria from contaminated personal items such as clothing or bedding.

The incubation period typically ranges from two to five days. During this time, you might not notice symptoms but can still spread the infection. Quick isolation and antibiotic treatment reduce the risk of transmission to others.

You face a higher risk of diphtheria if you are unvaccinated or not up to date with your booster doses. The disease remains more common in regions with limited access to routine immunization programs.

Close contact with an infected person—such as living in the same household or sharing utensils—increases your chances of catching the infection. Travelers to areas where diphtheria is still present should ensure their vaccinations are current.

Children, older adults, and people with weakened immune systems face greater complications from this infectious disease. Maintaining good hygiene and staying aware of local outbreaks help protect you and your community from this preventable childhood disease.

Accurate identification of diphtheria relies on both clinical evaluation and laboratory evidence. You must recognize symptoms early, confirm the presence of Corynebacterium diphtheriae, and distinguish it from other infections that cause similar throat or skin lesions. Prompt diagnosis ensures that treatment and isolation begin without delay.

You should suspect diphtheria when a patient presents with sore throat, fever, and a thick gray or white pseudomembrane over the tonsils or pharynx. This membrane may bleed if disturbed. Neck swelling, sometimes called “bull neck,” often signals toxin-related tissue inflammation.

A detailed history helps determine exposure risk, such as contact with an infected person or incomplete vaccination. Rapid clinical judgment is essential because waiting for lab results can delay life‑saving treatment.

Doctors often begin antitoxin and antibiotic therapy immediately if diphtheria is suspected. The Centers for Disease Control and Prevention (CDC) advises that treatment should not wait for confirmation, especially in respiratory cases with airway compromise. Clinical observation remains the foundation of early detection.

Definitive diagnosis depends on identifying Corynebacterium diphtheriae and confirming toxin production. You or your healthcare provider collect throat or nasal swabs from the affected area before antibiotics start. These samples are cultured on selective media to isolate the bacteria.

Once isolated, laboratories perform the Elek test (diphtheria antitoxin test, DAT) or polymerase chain reaction (PCR) to confirm toxin gene presence. PCR offers faster and more sensitive detection than culture alone.

Public health laboratories, often coordinated through the CDC, verify suspected diphtheria cases and monitor outbreaks. Reporting confirmed cases supports surveillance and guides vaccination strategies. Proper specimen handling and transport are critical for accurate results.

You must differentiate diphtheria from other causes of membranous pharyngitis or skin ulcers. Conditions such as streptococcal pharyngitis, infectious mononucleosis, Vincent’s angina, and candidiasis can appear similar but lack the diphtheritic toxin’s systemic effects.

In respiratory cases, airway obstruction may also mimic epiglottitis or severe tonsillitis. Laboratory testing helps rule out these conditions when the membrane’s appearance alone is inconclusive.

For cutaneous lesions, clinicians should consider impetigo, staphylococcal infections, or fungal ulcers. Evaluating vaccination history, travel, and exposure risk helps narrow the diagnosis. Accurate differentiation ensures that you receive the right treatment and that public health authorities can respond appropriately.

Prompt treatment prevents diphtheria from causing life‑threatening airway obstruction or organ damage. You need both targeted drug therapy and careful monitoring to control the infection and its complications.

When diphtheria is suspected, start treatment right away—do not wait for lab confirmation. The infection can progress quickly, so early action saves lives.

You will likely receive hospital care under droplet precautions to prevent spread. Clinicians collect throat or wound cultures before antibiotics if possible, but therapy begins immediately afterward.

If breathing becomes difficult due to the throat membrane, doctors may perform intubation or a tracheotomy to keep your airway open. Medical staff also monitor heart rhythm and nerve function because the toxin can affect these systems.

Treatment combines antitoxin and antibiotics. The diphtheria antitoxin (DAT) neutralizes circulating toxin but cannot reverse damage already done. Doctors obtain it through public health authorities, and it is given intravenously or intramuscularly.

For bacterial eradication, erythromycin or penicillin are the drugs of choice. These antibiotics stop Corynebacterium diphtheriae from multiplying and reduce transmission risk.

You continue antibiotics for about 14 days. After completion, two negative cultures taken 24 hours apart confirm that the bacteria are cleared. Patients who recover should receive a diphtheria‑containing vaccine because infection does not guarantee lasting immunity.

Severe diphtheria cases need intensive monitoring to manage airway, heart, and nerve complications. Continuous cardiac observation detects myocarditis, a toxin‑related inflammation that can cause irregular heartbeat.

If paralysis affects swallowing or breathing muscles, you may require mechanical ventilation or feeding support until nerve function returns.

Isolation continues until you are culture‑negative. Health authorities trace and treat close contacts with antibiotic prophylaxis and vaccination updates to stop further spread.

Supportive care includes fluid management, pain control, and careful observation for secondary infections. The goal is to stabilize vital functions while the antitoxin and antibiotics eliminate the bacteria and neutralize its toxin.

You can protect yourself and others from diphtheria through timely vaccination, booster doses, and strong public health measures. Maintaining high immunization coverage reduces the risk of outbreaks and keeps communities safe from this preventable bacterial disease.

The diphtheria vaccine uses an inactivated diphtheria toxoid, which trains your immune system to recognize and fight the toxin without causing illness. It’s often combined with vaccines for tetanus and pertussis in formulations such as DTaP, Tdap, or DT/Td.

The vaccine is safe and effective. Mild side effects like soreness or low fever may occur, but serious reactions are rare. Vaccination not only prevents diphtheria but also limits its spread to unvaccinated individuals.

Health authorities such as the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) recommend that everyone, especially children, receive all required doses and boosters to maintain long-term immunity.

You should receive a full primary series of diphtheria-containing vaccines, followed by booster doses throughout life. The standard schedule recommended by the CDC includes:

If you miss a dose, you should catch up as soon as possible. Pregnant individuals are advised to receive a Tdap booster during each pregnancy to protect newborns through passive immunity.

High community vaccination coverage is essential to prevent diphtheria outbreaks. Public health programs focus on routine immunization, booster campaigns, and surveillance to detect and control cases quickly.

Reaching under-immunized populations through mobile clinics or outreach programs helps close immunity gaps. During outbreaks, health authorities may provide mass vaccination and antibiotic prophylaxis to close contacts.

Maintaining vaccine records and following national immunization guidelines ensures sustained protection. Strong coordination between healthcare providers, laboratories, and public health agencies supports early detection and response to diphtheria cases.